The precise identification of a protein designated as "ES" presents a challenge due to the ambiguity of the acronym within the vast lexicon of protein nomenclature. The acronym "ES" could potentially refer to a variety of proteins depending on the context within which it is used, such as embryonic stem cells (in the context of stem cell biology) or specific enzymes or proteins identified by similar abbreviations in specialized fields of study. Without a specific and universally recognized protein associated directly with this abbreviation, a detailed discussion on the function and activation mechanisms of "ES" is inherently speculative and runs the risk of inaccuracies.
In the realm of scientific inquiry, the activation of proteins typically involves a complex interplay of biochemical and cellular mechanisms. Generally, protein activation can be facilitated through several universal mechanisms, including but not limited to, phosphorylation, allosteric modulation, proteolytic cleavage, and ligand binding. These mechanisms ensure that proteins are activated at the right time and place, allowing for the precise regulation of cellular processes. For instance, phosphorylation, a common post-translational modification, involves the addition of a phosphate group to a protein by a kinase, leading to a conformational change that either activates or increases the protein's activity. Allosteric modulation, on the other hand, entails the binding of a molecule at a site other than the protein's active site, inducing a structural rearrangement that enhances its functional activity.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP levels, which can activate numerous cellular pathways, potentially affecting STS. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates the cAMP-dependent pathway, which can indirectly influence STS. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Acts as a diacylglycerol (DAG) analog and activates protein kinase C (PKC), which could influence STS's associated pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Modulates intracellular calcium levels, activating calcium-related signaling cascades that can influence STS. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor; it can modulate the phosphoinositide 3-kinase (PI3K) pathway, which might influence proteins associated with STS. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK and influences the p38 MAPK signaling pathway, which might indirectly affect STS. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that offers a different mode of action to modulate the PI3K pathway, potentially influencing STS. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A specific inhibitor of MEK, it impacts the MAPK signaling pathway, which could have an indirect effect on STS. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that influences cellular growth and metabolism, potentially impacting pathways associated with STS. | ||||||
Tyrphostin AG 1478 | 175178-82-2 | sc-200613 sc-200613A | 5 mg 25 mg | $96.00 $421.00 | 16 | |
An EGFR tyrosine kinase inhibitor that modulates EGFR signaling, which can influence STS. | ||||||